The Medicines and Healthcare products Regulatory Agency (MHRA) has cleared the oral neurokinin (NK) 1 and 3 antagonist, under the Lynkuet brand name, for the treatment of moderate to severe vasomotor ...

In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...

The FDA has called a plan to publish certain complete response letters (CRLs) for medicines it has rejected after an initial ...

Looking back over the past five years, it's clear that healthcare professionals (HCPs) have faced incredible pressure and ...

In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a ...

New Evidation CEO Leslie Olay Wilberforce speaks at a Reuters event earlier this year. Earlier this year, San Francisco-based ...

"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...

A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...

The new data from the US Measles Tracker, hosted by the International Vaccine Access Center (IVAC) at the Johns Hopkins ...

The three-stage framework below guides organisations through their agentic AI journey, ensuring effective ecosystem ...